1. Home
  2. RGEN vs G Comparison

RGEN vs G Comparison

Compare RGEN & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$163.11

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$45.82

Market Cap

7.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
G
Founded
1981
1997
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.2B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
RGEN
G
Price
$163.11
$45.82
Analyst Decision
Buy
Buy
Analyst Count
11
7
Target Price
$177.18
$51.00
AVG Volume (30 Days)
600.1K
1.2M
Earning Date
02-19-2026
02-05-2026
Dividend Yield
N/A
1.48%
EPS Growth
N/A
N/A
EPS
0.03
3.10
Revenue
$707,890,000.00
$5,009,342,000.00
Revenue This Year
$17.86
$8.47
Revenue Next Year
$12.44
$6.90
P/E Ratio
$5,247.54
$14.81
Revenue Growth
11.74
7.39
52 Week Low
$102.97
$37.49
52 Week High
$182.52
$56.76

Technical Indicators

Market Signals
Indicator
RGEN
G
Relative Strength Index (RSI) 48.28 44.18
Support Level $158.80 $46.35
Resistance Level $172.51 $47.91
Average True Range (ATR) 6.24 0.98
MACD -0.83 -0.30
Stochastic Oscillator 25.84 15.20

Price Performance

Historical Comparison
RGEN
G

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About G Genpact Limited

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.

Share on Social Networks: